CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance
Abstract Cancer stem-like cells (CSCs) are associated with cancer progression, metastasis, and recurrence, and may also represent a subset of circulating tumor cells (CTCs). In our prior study, CTCs in advanced prostate cancer patients were found to express CD117/c-kit in a liquid biopsy. Whether CD...
Guardado en:
Autores principales: | Koran S. Harris, Lihong Shi, Brittni M. Foster, Mary E. Mobley, Phyllis L. Elliott, Conner J. Song, Kounosuke Watabe, Carl D. Langefeld, Bethany A. Kerr |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/31937ecc75f747969043b5ed6e2fc7e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.
por: Leyre Larzabal, et al.
Publicado: (2013) -
Author Correction: Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
por: Sook-Kyoung Heo, et al.
Publicado: (2021) -
Marcos Gregorio McGrath, C.S.C.: In memoriam
por: Donoso E.,Fermín
Publicado: (2000) -
Expresión Inmunohistoquímica de Vimentina, CD 34 y c-Kit (CD 117) en Tumores Estromales Gastrointestinales (GISTs)
por: Fonseca,Ismael Bernardo, et al.
Publicado: (2010) -
Management of VEGFR-Targeted TKI for Thyroid Cancer
por: Tomohiro Enokida, et al.
Publicado: (2021)